Crystal Rock Capital Management Boston Scientific Corp Transaction History
Crystal Rock Capital Management
- $155 Million
- Q4 2024
A detailed history of Crystal Rock Capital Management transactions in Boston Scientific Corp stock. As of the latest transaction made, Crystal Rock Capital Management holds 85,100 shares of BSX stock, worth $8.44 Million. This represents 4.89% of its overall portfolio holdings.
Number of Shares
85,100
Previous 91,525
7.02%
Holding current value
$8.44 Million
Previous $7.67 Million
0.89%
% of portfolio
4.89%
Previous 4.69%
Shares
12 transactions
Others Institutions Holding BSX
# of Institutions
1,669Shares Held
1.22BCall Options Held
8.76MPut Options Held
9.42M-
Vanguard Group Inc Valley Forge, PA133MShares$13.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA64MShares$6.35 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA36.9MShares$3.66 Billion2.61% of portfolio
-
Wellington Management Group LLP Boston, MA36.2MShares$3.59 Billion0.61% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $142B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...